CIK 0001088856
- Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770487658
- Phone
- +1 650-688-8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,491,788
- in 15 filings, $25.2M under 10b5-1 plans
Net −$28,491,788. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-27 | Hunt Hazel Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +140,000 | 140,000 | ||
| 2026-02-09 | Hunt Hazel Chief Scientific Officer | Exercise or conversion | +150,000 | $3.88 | $582K | 333,405 |
| 2026-02-09 | Hunt Hazel Chief Scientific Officer | Shares withheld for taxes | −77,968 | $41.31 | $3.2M | 255,437 |
| 2026-02-09 | Hunt Hazel Chief Scientific Officer | Exercise or conversion · Stock Option (right to buy) | −150,000 | 0 | ||
| 2025-02-28 | Hunt Hazel Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +140,000 | 140,000 | ||
| 2025-02-11 | Hunt Hazel Chief Scientific Officer | Exercise or conversion | +150,000 | $3.29 | $494K | 268,581 |
| 2025-02-11 | Hunt Hazel Chief Scientific Officer | Shares withheld for taxes | −85,176 | $68.11 | $5.8M | 183,405 |
| 2025-02-11 | Hunt Hazel Chief Scientific Officer | Exercise or conversion · Stock Option (right to buy) | −150,000 | 0 | ||
| 2024-08-01 | Hunt Hazel Chief Scientific Officer | Exercise or conversion | +60,000 | $2.81 | $169K | 153,354 |
| 2024-08-01 | Hunt Hazel Chief Scientific Officer | Shares withheld for taxes | −34,773 | $37.94 | $1.3M | 118,581 |
| 2024-08-01 | Hunt Hazel Chief Scientific Officer | Exercise or conversion · Stock Option (right to buy) | −60,000 | 0 | ||
| 2024-02-09 | Hunt Hazel Chief Scientific Officer | Grant or award · Stock option (right to buy) | +200,000 | 200,000 | ||
| 2024-01-08 | Hunt Hazel Chief Scientific Officer | Exercise or conversion | +50,000 | $3.02 | $151K | 123,146 |
| 2024-01-08 | Hunt Hazel Chief Scientific Officer | Shares withheld for taxes | −29,792 | $27.46 | $818K | 93,354 |
| 2024-01-08 | Hunt Hazel Chief Scientific Officer | Exercise or conversion · Stock Option (right to buy) | −50,000 | 0 | ||
| 2023-08-14 | Hunt Hazel Chief Scientific Officer | Sale | −20,455 | $30.89 | $632K | 73,146 |
| 2023-08-08 | Hunt Hazel Chief Scientific Officer | Exercise or conversion | +50,000 | $3.02 | $151K | 123,146 |
| 2023-08-08 | Hunt Hazel Chief Scientific Officer | Shares withheld for taxes | −29,545 | $30.48 | $901K | 93,601 |
| 2023-08-08 | Hunt Hazel Chief Scientific Officer | Exercise or conversion · Stock option (right to buy) | −50,000 | 0 | ||
| 2023-02-13 | Hunt Hazel Chief Scientific Officer | Grant or award · Stock option (right to buy) | +200,000 | 200,000 |
Page 1 of 2 · 35 trades